ENHYPEN has officially scored its first No. 1 album on the Billboard 200. The group’s latest mini album, The Sin: Blossom, debuted at the top of the chart dated for the tracking week ending August 28, according to Billboard’s official report. It marks a major commercial breakthrough for the seven-member act under Belift Lab and HYBE.
The project moved 142,000 equivalent album units in the United States in its first week. Of that total, 133,000 came from pure album sales, driven heavily by CD and vinyl purchases. Streaming and track equivalent albums made up the rest. This performance also gives ENHYPEN its highest-charting entry to date and its fourth top-10 album on the Billboard 200.
For global fans who follow Korean releases more closely than U.S. chart mechanics, the context matters. ENHYPEN formed through the 2020 survival show I-LAND and has steadily climbed Western charts since its early releases. Previous projects such as Dark Blood and Romance: Untold had already cracked the top 10. The group is currently promoting the new album with a series of music-show appearances in Korea and has additional tour dates planned later this year, building on the momentum of their recent world tour stops.
International fans reacted quickly once the chart update dropped. Many posted celebratory messages noting the pure-sales strength and calling the No. 1 a long-awaited validation after years of consistent growth. Online discussions highlighted the album’s physical sales dominance and expressed excitement about what the milestone could mean for future U.S. promotions and larger arena shows.
The achievement places ENHYPEN among a smaller group of K-pop acts that have reached the summit of the Billboard 200, underscoring both the dedicated fanbase’s purchasing power and the group’s expanding commercial reach outside Asia